Neenah Reports Record Sales for the Third Quarter 2021
Neenah, Inc. (NYSE: NP) reported a record net sales of $267.9 million for Q3 2021, a 40% increase from last year, driven by robust organic growth and the Itasa acquisition. Technical Products sales rose 46%, while Fine Paper and Packaging grew 32%. However, operating income fell to $11.4 million due to rising input costs and supply chain disruptions. Adjusted EPS was $0.38, down from $0.55 YoY, amid higher expenses and a challenging operating environment. Liquidity remained strong at $190 million. The company is focused on recovering margins through pricing strategies and expanding into larger markets.
- Record net sales of $267.9 million, up 40% YoY.
- Technical Products sales increased 46%, driven by organic growth.
- Fine Paper and Packaging net sales grew 32%, reflecting strong demand.
- Liquidity remains robust at $190 million.
- Operating income decreased to $11.4 million, down $2.5 million YoY.
- Adjusted EPS fell to $0.38 from $0.55, due to rising input costs.
- Increased SG&A expenses of $26.1 million due to Itasa acquisition.
- Higher distribution costs affected by supply chain constraints.
Third Quarter Highlights
-
Record net sales of
were up 40 percent from prior year, with strong performance in each segment. Excluding the effects of the Itasa acquisition, net sales were 22 percent higher than prior year.$267.9 million - Record net sales in Technical Products were led by organic growth in all product categories. Net sales were up 46 percent from prior year, including sales from the Itasa acquisition. Excluding the acquisition, quarterly sales were up 15 percent from prior year.
-
Net sales in
Fine Paper and Packaging were up 32 percent from prior year, driven by record sales in premium packaging and growth in consumer products. -
As expected, operating margin was pressured by unprecedented increases in input costs and supply chain disruptions, as well as the effects of flooding from Hurricane Ida at our
Pennsylvania facility. -
Liquidity remained strong at
as of$190 million September 30, 2021 . -
Itasa was awarded the
EcoVadis 2021 Gold Medal for Sustainability, a key designation demonstrating our commitment to sustainable manufacturing practices.
Adjusted earnings is a non-GAAP measure used to enhance understanding and comparability of year-on-year results. Details on adjusting items and a reconciliation to comparable GAAP measures are included later in this release.
"Neenah continues to deliver strong top-line performance, with growing demand for our products in both business segments. As expected, margins were impacted by rapidly escalating raw material and energy costs this quarter, as well as supply chain disruptions,” said
Quarterly Consolidated Results
Income Statement
Consolidated net sales of
Selling, general and administrative (SG&A) expense of
Operating income of
Net interest expense of
The effective income tax rate provision applied to the pre-tax income was 48 percent and 23 percent in the third quarter of 2021 and 2020, respectively. The tax provision was impacted in 2021 by a
The GAAP earnings per diluted common share of
Cash Flow and Balance Sheet Items
Cash provided from operations of
Capital spending of
Cash dividends of
Cash and cash equivalents as of
Quarterly Segment Results
Technical Products quarterly net sales of
Operating income decreased
Operating income increased
Unallocated Corporate costs in the third quarter of 2021 of
Year-to-Date
Consolidated net sales of
Consolidated operating loss improved by
The year-to-date net loss improved by
The year-to-date loss per diluted common share of
Cash provided by operating activities of
Capital expenditures for the nine months ended
Debt as of
Reconciliation to GAAP Measures
The Company will report adjustments to GAAP figures when they are believed to improve the comparability and understanding of results.
A reconciliation of adjusted income measures to comparable GAAP measures is provided below:
|
|
Third Quarter |
|
YTD |
|||||||||||||||
($ Millions, except share and per share data) |
|
2021 |
|
|
2020 |
|
2021 |
|
|
2020 |
|
||||||||
GAAP Operating Income (Loss) |
|
$ |
11.4 |
|
|
|
$ |
13.9 |
|
|
$ |
(7.6 |
) |
|
|
$ |
(21.0 |
) |
|
Impairment and asset restructuring costs |
|
(0.4 |
) |
|
|
— |
|
|
37.0 |
|
|
|
55.3 |
|
|
||||
Acquisition and integration costs |
|
0.6 |
|
|
|
— |
|
|
17.8 |
|
|
|
1.1 |
|
|
||||
Other restructuring and non-routine |
|
0.6 |
|
|
|
1.4 |
|
|
1.5 |
|
|
|
4.1 |
|
|
||||
COVID-19 costs |
|
0.5 |
|
|
|
0.6 |
|
|
1.2 |
|
|
|
2.1 |
|
|
||||
Loss on debt extinguishment |
|
— |
|
|
|
— |
|
|
7.2 |
|
|
|
1.9 |
|
|
||||
Pension settlement costs |
|
— |
|
|
|
— |
|
|
1.0 |
|
|
|
— |
|
|
||||
Adjusted Operating Income |
|
$ |
12.7 |
|
|
|
$ |
15.9 |
|
|
$ |
58.1 |
|
|
|
$ |
43.5 |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
GAAP Net Income (Loss) |
|
$ |
3.3 |
|
|
|
$ |
7.9 |
|
|
$ |
(18.1 |
) |
|
|
$ |
(25.8 |
) |
|
Impairment and asset restructuring costs |
|
(0.3 |
) |
|
|
— |
|
|
27.7 |
|
|
|
42.0 |
|
|
||||
Acquisition and integration costs |
|
0.5 |
|
|
|
— |
|
|
13.4 |
|
|
|
0.8 |
|
|
||||
Other restructuring and non-routine |
|
0.4 |
|
|
|
1.1 |
|
|
1.1 |
|
|
|
3.1 |
|
|
||||
COVID-19 costs |
|
0.4 |
|
|
|
0.4 |
|
|
0.9 |
|
|
|
1.6 |
|
|
||||
Loss on debt extinguishment |
|
— |
|
|
|
— |
|
|
5.4 |
|
|
|
1.4 |
|
|
||||
Pension settlement costs |
|
— |
|
|
|
— |
|
|
0.8 |
|
|
|
— |
|
|
||||
Income tax adjustments |
|
2.2 |
|
|
|
— |
|
|
4.0 |
|
|
|
4.0 |
|
|
||||
Adjusted Net Income |
|
$ |
6.5 |
|
|
|
$ |
9.4 |
|
|
$ |
35.2 |
|
|
|
$ |
27.1 |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
GAAP Earnings (Loss) per Diluted Common Share |
|
$ |
0.19 |
|
|
|
$ |
0.46 |
|
|
$ |
(1.09 |
) |
|
|
$ |
(1.55 |
) |
|
Impairment and asset restructuring costs |
|
(0.02 |
) |
|
|
— |
|
|
1.64 |
|
|
|
2.50 |
|
|
||||
Acquisition and integration costs |
|
0.03 |
|
|
|
— |
|
|
0.79 |
|
|
|
0.04 |
|
|
||||
Other restructuring and non-routine |
|
0.02 |
|
|
|
0.06 |
|
|
0.07 |
|
|
|
0.18 |
|
|
||||
COVID-19 costs |
|
0.03 |
|
|
|
0.03 |
|
|
0.05 |
|
|
|
0.10 |
|
|
||||
Loss on debt extinguishment |
|
— |
|
|
|
— |
|
|
0.32 |
|
|
|
0.08 |
|
|
||||
Pension settlement costs |
|
— |
|
|
|
— |
|
|
0.05 |
|
|
|
— |
|
|
||||
Income tax adjustments |
|
0.13 |
|
|
|
— |
|
|
0.24 |
|
|
|
0.24 |
|
|
||||
Adjusted Earnings per Share |
|
$ |
0.38 |
|
|
|
$ |
0.55 |
|
|
$ |
2.07 |
|
|
|
$ |
1.59 |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Diluted Shares (in thousands) |
|
16,867 |
|
|
|
16,821 |
|
|
16,871 |
|
|
|
16,810 |
|
|
Conference Call
A conference call and webcast to discuss third quarter earnings and other matters of interest will be held as noted below. Investors and participants who wish to actively participate in the call should register for the earnings call in advance by visiting the Direct Entry link https://conferencingportals.com/event/WFVbrllr. After registering, instructions will be shared on how to join the call. The webcast will be available on Neenah’s website under Presentations & Events.
Supplemental Information can be found on the Company’s web site under the Investor Relations - Presentations & Events section.
A replay of the call will be available until
Encore Dial In #: (800) 770-2030 or (647) 362-9199
Replay Access Code: 56609
About Neenah
Neenah is committed to manufacturing growth for its customers, end-users, shareholders, and employees. With manufacturing facilities across
Cautionary Note Regarding Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking” statements as defined under the federal securities laws. Statements contained in this press release that are not historical facts may be forward-looking statements within the meaning of the federal securities laws and caution is given to investors that any forward-looking statements are not guarantees or indicative of future performance. These forward-looking statements rely on a number of assumptions concerning future events and are subject to risks, uncertainties and other factors, many of which are outside the Company's control and could cause actual results to materially differ from such statements. Such risks, uncertainties and other factors include, but are not necessarily limited to, those set forth under the captions “Cautionary Note Regarding Forward-Looking Statements” and/or “Risk Factors” of the latest Form 10-K filed with the
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In millions, except share and per share data) (Unaudited) |
|||||||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
|||||||||||||||
|
|
2021 |
|
|
2020 |
|
2021 |
|
|
2020 |
|
||||||||
|
|
$ |
267.9 |
|
|
|
$ |
190.7 |
|
|
$ |
764.2 |
|
|
|
$ |
585.7 |
|
|
Cost of products sold |
|
229.5 |
|
|
|
155.5 |
|
|
637.8 |
|
|
|
475.1 |
|
|
||||
Gross Profit |
|
38.4 |
|
|
|
35.2 |
|
|
126.4 |
|
|
|
110.6 |
|
|
||||
Selling, general and administrative expenses |
|
26.1 |
|
|
|
19.1 |
|
|
77.9 |
|
|
|
66.5 |
|
|
||||
Impairment and asset restructuring costs |
|
0.4 |
|
|
|
— |
|
|
34.8 |
|
|
|
55.3 |
|
|
||||
Acquisition and integration costs |
|
0.3 |
|
|
|
— |
|
|
12.4 |
|
|
|
1.1 |
|
|
||||
Other restructuring and non-routine costs |
|
0.6 |
|
|
|
1.4 |
|
|
1.5 |
|
|
|
4.1 |
|
|
||||
COVID-19 costs |
|
0.5 |
|
|
|
0.6 |
|
|
1.2 |
|
|
|
2.1 |
|
|
||||
Loss on debt extinguishment |
|
— |
|
|
|
— |
|
|
7.2 |
|
|
|
1.9 |
|
|
||||
Pension settlement losses |
|
— |
|
|
|
— |
|
|
1.0 |
|
|
|
— |
|
|
||||
Other (income) expense - net |
|
(0.9 |
) |
|
|
0.2 |
|
|
(2.0 |
) |
|
|
0.6 |
|
|
||||
Operating Income (Loss) |
|
11.4 |
|
|
|
13.9 |
|
|
(7.6 |
) |
|
|
(21.0 |
) |
|
||||
Interest expense - net |
|
5.1 |
|
|
|
3.6 |
|
|
13.0 |
|
|
|
9.5 |
|
|
||||
Income (Loss) Before Income Taxes |
|
6.3 |
|
|
|
10.3 |
|
|
(20.6 |
) |
|
|
(30.5 |
) |
|
||||
Provision (Benefit) for income taxes |
|
3.0 |
|
|
|
2.4 |
|
|
(2.5 |
) |
|
|
(4.7 |
) |
|
||||
Net Income (Loss) |
|
$ |
3.3 |
|
|
|
$ |
7.9 |
|
|
$ |
(18.1 |
) |
|
|
$ |
(25.8 |
) |
|
|
|
|
|
|
|
|
|
|
|||||||||||
Earnings (Loss) Per Common Share |
|
|
|
|
|
|
|
|
|||||||||||
Basic |
|
$ |
0.19 |
|
|
|
$ |
0.46 |
|
|
$ |
(1.09 |
) |
|
|
$ |
(1.55 |
) |
|
Diluted |
|
$ |
0.19 |
|
|
|
$ |
0.46 |
|
|
$ |
(1.09 |
) |
|
|
$ |
(1.55 |
) |
|
|
|
|
|
|
|
|
|
|
|||||||||||
Weighted Average Common Shares Outstanding (in thousands) |
|
|
|
|
|
|
|
|
|||||||||||
Basic |
|
16,827 |
|
|
|
16,802 |
|
|
16,831 |
|
|
|
16,810 |
|
|
||||
Diluted |
|
16,867 |
|
|
|
16,821 |
|
|
16,831 |
|
|
|
16,810 |
|
|
BUSINESS SEGMENT DATA (In millions) (Unaudited) |
||||||||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
Technical Products |
|
$ |
172.7 |
|
|
|
$ |
118.5 |
|
|
|
$ |
497.5 |
|
|
|
$ |
351.4 |
|
|
|
|
95.2 |
|
|
|
72.2 |
|
|
|
266.7 |
|
|
|
234.3 |
|
|
||||
Consolidated |
|
$ |
267.9 |
|
|
|
$ |
190.7 |
|
|
|
$ |
764.2 |
|
|
|
$ |
585.7 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Operating Income (Loss): |
|
|
|
|
|
|
|
|
||||||||||||
Technical Products |
|
$ |
10.0 |
|
|
|
$ |
13.1 |
|
|
|
$ |
0.9 |
|
|
|
$ |
(17.8 |
) |
|
|
|
6.4 |
|
|
|
5.2 |
|
|
|
29.0 |
|
|
|
15.7 |
|
|
||||
Unallocated corporate costs |
|
(5.0 |
) |
|
|
(4.4 |
) |
|
|
(37.5 |
) |
|
|
(18.9 |
) |
|
||||
Consolidated |
|
$ |
11.4 |
|
|
|
$ |
13.9 |
|
|
|
$ |
(7.6 |
) |
|
|
$ |
(21.0 |
) |
|
RECONCILIATION OF SEGMENT OPERATING INCOME (LOSS) (millions) (Unaudited) |
||||||||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||||
Technical Products |
|
|
|
|
|
|
|
|
||||||||||||
GAAP operating income (loss) |
|
$ |
10.0 |
|
|
|
$ |
13.1 |
|
|
|
$ |
0.9 |
|
|
|
$ |
(17.8 |
) |
|
Impairment and asset restructuring costs |
|
(0.4 |
) |
|
|
— |
|
|
|
37.0 |
|
|
|
51.6 |
|
|
||||
Acquisition and integration costs |
|
0.6 |
|
|
|
— |
|
|
|
5.7 |
|
|
|
— |
|
|
||||
Other restructuring and non-routine |
|
0.4 |
|
|
|
— |
|
|
|
1.0 |
|
|
|
0.3 |
|
|
||||
COVID-19 costs |
|
0.2 |
|
|
|
0.2 |
|
|
|
0.4 |
|
|
|
0.9 |
|
|
||||
Loss on debt extinguishment |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.1 |
|
|
||||
Adjusted Operating Income |
|
10.8 |
|
|
|
13.3 |
|
|
|
45.0 |
|
|
|
35.1 |
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
GAAP operating income |
|
6.4 |
|
|
|
5.2 |
|
|
|
29.0 |
|
|
|
15.7 |
|
|
||||
Asset restructuring costs |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3.7 |
|
|
||||
Other restructuring and non-routine |
|
(0.1 |
) |
|
|
0.4 |
|
|
|
(0.2 |
) |
|
|
2.2 |
|
|
||||
COVID-19 costs |
|
0.3 |
|
|
|
0.4 |
|
|
|
0.6 |
|
|
|
1.0 |
|
|
||||
Adjusted Operating Income |
|
6.6 |
|
|
|
6.0 |
|
|
|
29.4 |
|
|
|
22.6 |
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||||||
Unallocated Corporate Costs |
|
|
|
|
|
|
|
|
||||||||||||
GAAP Operating Loss |
|
(5.0 |
) |
|
|
(4.4 |
) |
|
|
(37.5 |
) |
|
|
(18.9 |
) |
|
||||
Acquisition and integration costs |
|
— |
|
|
|
— |
|
|
|
12.1 |
|
|
|
1.1 |
|
|
||||
Other restructuring and non-routine |
|
0.3 |
|
|
|
1.0 |
|
|
|
0.7 |
|
|
|
1.6 |
|
|
||||
COVID-19 costs |
|
— |
|
|
|
— |
|
|
|
0.2 |
|
|
|
0.2 |
|
|
||||
Loss on debt extinguishment |
|
— |
|
|
|
— |
|
|
|
7.2 |
|
|
|
1.8 |
|
|
||||
Pension settlement costs |
|
— |
|
|
|
— |
|
|
|
1.0 |
|
|
|
— |
|
|
||||
Adjusted Operating Loss |
|
(4.7 |
) |
|
|
(3.4 |
) |
|
|
(16.3 |
) |
|
|
(14.2 |
) |
|
||||
|
|
|
|
|
|
|
|
|
||||||||||||
Consolidated |
|
|
|
|
|
|
|
|
||||||||||||
GAAP operating income (loss) |
|
11.4 |
|
|
|
13.9 |
|
|
|
(7.6 |
) |
|
|
(21.0 |
) |
|
||||
Impairment and asset restructuring costs |
|
(0.4 |
) |
|
|
— |
|
|
|
37.0 |
|
|
|
55.3 |
|
|
||||
Acquisition and integration costs |
|
0.6 |
|
|
|
— |
|
|
|
17.8 |
|
|
|
1.1 |
|
|
||||
Other restructuring and non-routine |
|
0.6 |
|
|
|
1.4 |
|
|
|
1.5 |
|
|
|
4.1 |
|
|
||||
COVID-19 costs |
|
0.5 |
|
|
|
0.6 |
|
|
|
1.2 |
|
|
|
2.1 |
|
|
||||
Loss on debt extinguishment |
|
— |
|
|
|
— |
|
|
|
7.2 |
|
|
|
1.9 |
|
|
||||
Pension settlement costs |
|
— |
|
|
|
— |
|
|
|
1.0 |
|
|
|
— |
|
|
||||
Adjusted Operating Income |
|
$ |
12.7 |
|
|
|
$ |
15.9 |
|
|
|
$ |
58.1 |
|
|
|
$ |
43.5 |
|
|
SELECTED BALANCE SHEET DATA (In millions) (Unaudited) |
||||||||
|
|
|
|
|
||||
ASSETS |
|
|
|
|
||||
Current Assets |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
31.7 |
|
|
$ |
37.1 |
|
Accounts receivable - net |
|
150.4 |
|
|
100.2 |
|
||
Inventories |
|
133.8 |
|
|
108.9 |
|
||
Assets held for sale |
|
10.6 |
|
|
— |
|
||
Prepaid and other current assets |
|
32.4 |
|
|
25.1 |
|
||
Total Current Assets |
|
358.9 |
|
|
271.3 |
|
||
Property, Plant and Equipment - net |
|
295.1 |
|
|
329.4 |
|
||
Finance Lease Right-of-Use Assets |
|
21.3 |
|
|
— |
|
||
Operating Lease Right-of-Use Assets |
|
18.4 |
|
|
20.2 |
|
||
Deferred Income Taxes |
|
25.1 |
|
|
18.3 |
|
||
|
|
202.2 |
|
|
87.4 |
|
||
Intangible Assets - net |
|
159.0 |
|
|
62.6 |
|
||
Other Noncurrent Assets |
|
13.0 |
|
|
17.4 |
|
||
Total Assets |
|
$ |
1,093.0 |
|
|
$ |
806.6 |
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
||||
Current Liabilities |
|
|
|
|
||||
Debt payable within one year |
|
$ |
7.1 |
|
|
$ |
4.9 |
|
Finance lease liabilities payable within one year |
|
0.8 |
|
|
— |
|
||
Operating lease liabilities payable within one year |
|
3.3 |
|
|
3.2 |
|
||
Accounts payable |
|
94.8 |
|
|
46.0 |
|
||
Liabilities held for sale |
|
0.6 |
|
|
— |
|
||
Accrued expenses |
|
72.9 |
|
|
61.9 |
|
||
Total Current Liabilities |
|
179.5 |
|
|
116.0 |
|
||
Long-term Debt |
|
434.6 |
|
|
189.5 |
|
||
Finance lease liabilities, noncurrent |
|
20.8 |
|
|
— |
|
||
Operating lease liabilities, noncurrent |
|
16.5 |
|
|
18.4 |
|
||
Noncurrent Employee Benefits |
|
70.9 |
|
|
96.8 |
|
||
Deferred Income Taxes |
|
37.4 |
|
|
12.3 |
|
||
Other Noncurrent Obligations |
|
5.9 |
|
|
6.0 |
|
||
Total Liabilities |
|
765.6 |
|
|
439.0 |
|
||
Stockholders’ Equity |
|
327.4 |
|
|
367.6 |
|
||
Total Liabilities and Stockholders’ Equity |
|
$ |
1,093.0 |
|
|
$ |
806.6 |
|
SELECTED CASH FLOW DATA (In millions) (Unaudited) |
||||||||||
|
|
Nine Months Ended |
||||||||
|
|
2021 |
|
2020 |
||||||
Operating Activities |
|
|
|
|
||||||
Net Loss |
|
$ |
(18.1 |
) |
|
|
$ |
(25.8 |
) |
|
Depreciation and amortization |
|
31.8 |
|
|
|
28.2 |
|
|
||
Stock-based compensation |
|
3.9 |
|
|
|
3.4 |
|
|
||
Deferred income tax benefit |
|
(12.9 |
) |
|
|
(11.3 |
) |
|
||
Impairment loss |
|
32.4 |
|
|
|
52.3 |
|
|
||
Loss on debt extinguishment |
|
7.2 |
|
|
|
1.9 |
|
|
||
Loss on foreign currency forward contracts |
|
5.1 |
|
|
|
— |
|
|
||
Pension settlement and other benefit costs |
|
1.3 |
|
|
|
— |
|
|
||
Provision for uncollectible accounts receivable |
|
— |
|
|
|
0.7 |
|
|
||
Loss on asset dispositions |
|
0.4 |
|
|
|
— |
|
|
||
Decrease (increase) in working capital |
|
(3.1 |
) |
|
|
28.7 |
|
|
||
Pension and other postretirement benefits |
|
(7.4 |
) |
|
|
(0.3 |
) |
|
||
Long-term payroll taxes |
|
— |
|
|
|
2.9 |
|
|
||
Other |
|
(0.3 |
) |
|
|
(0.3 |
) |
|
||
Net cash provided by operating activities |
|
40.3 |
|
|
|
80.4 |
|
|
||
|
|
|
|
|
||||||
Investing Activities |
|
|
|
|
||||||
Capital expenditures |
|
(19.0 |
) |
|
|
(11.8 |
) |
|
||
Acquisition of Itasa |
|
(240.2 |
) |
|
|
— |
|
|
||
Sale (purchase) of marketable securities |
|
3.7 |
|
|
|
(0.1 |
) |
|
||
Other |
|
(0.1 |
) |
|
|
(0.3 |
) |
|
||
Net cash used in investing activities |
|
(255.6 |
) |
|
|
(12.2 |
) |
|
||
|
|
|
|
|
||||||
Financing Activities |
|
|
|
|
||||||
Long-term borrowings |
|
457.5 |
|
|
|
291.2 |
|
|
||
Repayments of long-term debt |
|
(209.8 |
) |
|
|
(294.3 |
) |
|
||
Debt issuance costs |
|
(9.0 |
) |
|
|
(5.4 |
) |
|
||
Cash dividends paid |
|
(23.9 |
) |
|
|
(23.9 |
) |
|
||
Shares purchased |
|
(3.6 |
) |
|
|
(3.8 |
) |
|
||
Other |
|
(0.5 |
) |
|
|
— |
|
|
||
Net cash provided by (used in) financing activities |
|
210.7 |
|
|
|
(36.2 |
) |
|
||
|
|
|
|
|
||||||
Effect of exchange rates on cash and cash equivalents |
|
(0.8 |
) |
|
|
0.3 |
|
|
||
Net increase (decrease) in cash and cash equivalents |
|
(5.4 |
) |
|
|
32.3 |
|
|
||
Cash and cash equivalents, beginning of the year |
|
37.1 |
|
|
|
9.0 |
|
|
||
Cash and cash equivalents, end of period |
|
$ |
31.7 |
|
|
|
$ |
41.3 |
|
|
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20211102006230/en/
Vice President, Corporate Strategy and Investor Relations
(678) 518-3278
investors@neenah.com
Source:
FAQ
What were Neenah's net sales in Q3 2021?
How did Neenah's EPS change in Q3 2021?
What is Neenah's liquidity as of Q3 2021?
What impact did rising costs have on Neenah's operating income?